de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, et al. (2004). „Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition”. Ther Drug Monit26 (2), 137–144. o. DOI:10.1097/00007691-200404000-00009. PMID 15228154.
Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, Varner KJ (2002). „Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy”. J Pharmacol Exp Ther302 (3), 898–907. o. DOI:10.1124/jpet.302.3.898. PMID 12183645.
Tiangco DA, Halcomb S, Lattanzio FA, Jr., Hargrave BY (2010). „3,4-Methylenedioxymethamphetamine alters left ventricular function and activates nuclear factor-kappa B (NF-kB) in a time and dose dependent manner”. Int J Mol Sci11 (12), 4843–4863. o. DOI:10.3390/ijms11124743.
Mende L, Böhm R, Regenthal R, Klein N, Grond S, Radke J (2005). „Cardiac arrest caused by an ecstasy intoxication”. Anasthesiol Intensivmed Notfallmed Schmerzther40 (12), 762–765. o. DOI:10.1055/s-2005-870500. PMID 16362878.
Auer J, Berent R, Weber T, Lassnig E, Eber B (2002). „Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult”. Neurol Sci23 (4), 199–201. o. DOI:10.1007/s100720200062. PMID 12536290.
Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA (2006). „Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques”. Neuroscience142 (2), 515–525. o. DOI:10.1016/j.neuroscience.2006.06.033. PMID 16876329.
Sharma HS, Ali SF (2008). „Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood–brain barrier disruption, brain edema formation, and cell injury”. Ann N Y Acad Sci1139, 242–258. o. DOI:10.1196/annals.1432.052. PMID 18991870.
Peroutka SJ, Newman H, Harris H (1988). „Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users”. Neuropsychopharmacology1 (4), 273–277. o. PMID 2908020.
Chummun H, Tilley V, Ibe J (2010). „3,4-methylenedioxyamfetamine (ecstasy) use reduces cognition”. Br J Nurs19 (2), 94–100. o. PMID 20235382.
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, et al. (2004). „Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition”. Ther Drug Monit26 (2), 137–144. o. DOI:10.1097/00007691-200404000-00009. PMID 15228154.
Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, Varner KJ (2002). „Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy”. J Pharmacol Exp Ther302 (3), 898–907. o. DOI:10.1124/jpet.302.3.898. PMID 12183645.
Mende L, Böhm R, Regenthal R, Klein N, Grond S, Radke J (2005). „Cardiac arrest caused by an ecstasy intoxication”. Anasthesiol Intensivmed Notfallmed Schmerzther40 (12), 762–765. o. DOI:10.1055/s-2005-870500. PMID 16362878.
Auer J, Berent R, Weber T, Lassnig E, Eber B (2002). „Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult”. Neurol Sci23 (4), 199–201. o. DOI:10.1007/s100720200062. PMID 12536290.
Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA (2006). „Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques”. Neuroscience142 (2), 515–525. o. DOI:10.1016/j.neuroscience.2006.06.033. PMID 16876329.
Sharma HS, Ali SF (2008). „Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood–brain barrier disruption, brain edema formation, and cell injury”. Ann N Y Acad Sci1139, 242–258. o. DOI:10.1196/annals.1432.052. PMID 18991870.
University of Maryland, College Park Center for Substance Abuse Research: Ecstasy:CESAR. [2013. május 7-i dátummal az eredetiből archiválva]. (Hozzáférés: 2011. december 22.)
University of Maryland, College Park Center for Substance Abuse Research: Ecstasy:CESAR. [2013. május 7-i dátummal az eredetiből archiválva]. (Hozzáférés: 2011. december 22.)
